secwatch / observer

Equity Issuances

Unregistered sales and modifications of equity under 8-K Items 3.02/3.03.

8-K items 3.02, 3.03 JSON
STME Stimcell Energetics Inc.

Stimcell Energetics Inc. issued 250,000 shares of common stock to Stonegate.

“On March 19, 2026, the Company issued 250,000 shares of its common stock to Stonegate as consideration for the services provided under the Advisory Services Agreement”
BLNE Beeline Holdings, Inc.

Beeline Holdings, Inc. issued exchanged its remaining 4,425,102 shares of Series A for 983,356 shares of common stock of preferred stock to holder of the outstanding shares of the Company's Series A Convertible Redeemable Preferred Stock.

“On March 18, 2026, Beeline Holdings, Inc. (the “Company”) entered into an agreement with the holder of the outstanding shares of the Company’s Series A Convertible Redeemable Preferred Stock (the “Series A”) pursuant to which the holder exchanged its remaining 4,425,102 shares of Series A for 983,356 shares of the Company’s common stock, determined by dividing the stated value of the Series A by $2.25.”
Carlyle Credit Solutions, Inc.

Carlyle Credit Solutions, Inc. issued 353,591 shares of common stock for $6.6 million aggregate.

“As of March 1, 2026, Carlyle Credit Solutions, Inc. (the “Company”) issued and sold 353,591 shares of the Company’s Class I common stock, par value $0.01 per share (the “Class I Common Stock”), with the final number of shares being determined on March 19, 2026 for aggregate consideration of $6.6 million.”
Monroe Capital Income Plus Corp

Monroe Capital Income Plus Corp issued 2,876,264 shares of its common stock of common stock to each investor in the registrant for $9.80 per share.

“On March 2, 2026, Monroe Capital Income Plus Corporation (the "Company") issued an aggregate of 2,876,264 shares of its common stock, par value $0.01 per share (the “Common Stock”), at a price per share of $9.80 (with the final number of shares being determined on March 20, 2026), for an aggregate offering price of $28,187,391.”
Blackstone Private Credit Fund

Blackstone Private Credit Fund issued 350,808 of common stock for $8,552,705.

“details the shares sold: Date of Unregistered Sale Amount of Class I Common Shares Consideration As of March 1, 2026 (number of shares finalized on March 19, 2026) 350,808 $ 8,552,705”
MRLN Merlin, Inc.

Merlin, Inc. issued 9,803,922 shares of Series A Preferred Stock and 1,666,668 shares of Series A Preferred Stock of preferred stock to PIPE Investors for total purchase price of $100.0 million and $20 million respectively.

“Inflection Point issued and sold to the PIPE Investors (substantially concurrently with the consummation of the Transactions) an aggregate of (i) 9,803,922 shares of the Series A Preferred Stock and (ii) New Merlin Series A Warrants to purchase shares of Common Stock, for a total purchase price of $100.0 million (the “ Initial PIPE Investment ”).”
EQT Infrastructure Co LLC

EQT Infrastructure Co LLC issued 5,703,741 of common stock to third-party investors for aggregate consideration of approximately $146,748,589, at a price per Investor Share equal to transactional net asset value.

“As of March 1, 2026, EQT Infrastructure Company LLC (the “Company”) sold unregistered shares (the “Investor Shares”) of the Company to third-party investors for cash for aggregate consideration of approximately $146,748,589, at a price per Investor Share equal to transactional net asset value (“Transactional Net Asset Value”) per share for the applicable class, which corresponds to the price at which the Company sells and repurchases its shares.”
EQT Private Equity Co LLC

EQT Private Equity Co LLC issued 2,638,363 shares of common stock to third-party investors for $74,966,966 aggregate.

“As of March 1, 2026, EQT Private Equity Company LLC (the “Company”) sold unregistered shares (the “Investor Shares”) of the Company to third-party investors for cash for aggregate consideration of approximately $74,966,966, at a price per Investor Share equal to transactional net asset value (“Transactional Net Asset Value”) per share for the applicable class, which corresponds to the price at which the Company sells and repurchases its shares.”
Ares Sports, Media & Entertainment Opportunities LP

Ares Sports, Media & Entertainment Opportunities LP issued 10,558 Class S Units; 2,914 Class D Units; 2,910 Class N Units; 53,011 Class I Units; 762,605 Class A-S Units; 4,757 Class A-D Units; 2,910 Class A-N Units; 632 of unit to accredited investors for aggregate consideration of approximately $39.8 million.

“On March 1, 2026, Ares Sports, Media and Entertainment Opportunities LP (the “Fund”) sold unregistered limited partnership units (the “Units”) for aggregate consideration of approximately $39.8 million.”
BHAV BHAV Acquisition Corp

BHAV Acquisition Corp issued 200,000 private placement units of unit to the Sponsor and the at-risk capital investors for $10.00 per Private Unit.

“the Company completed the private sale of an aggregate of 200,000 private placement units (the "Private Units"), consisting of an aggregate of (i) 135,000 Private Units to the Sponsor and (ii) 65,000 Private Units to the at-risk capital investors, which were sold at a purchase price of $10.00 per Private Unit, generating aggregate gross proceeds to the Company of $2,000,000.”
CD Chaince Digital Holdings Inc.

Chaince Digital Holdings Inc. issued 6,500,000 ordinary shares of common stock to six non-U.S. investors for $0.774 per ordinary share, $5,031,000 total.

“the Company agreed to sell an aggregate of 6,500,000 ordinary shares of the Company, par value $0.004 per share, at a purchase price of $0.774 per ordinary share, for a total purchase price of $5,031,000 (the “Offering”), in reliance upon the exemption provided by Rule 903 of Regulation S”
ACON Aclarion, Inc.

Aclarion, Inc. issued common stock.

“On March 19, 2026, the board of directors (the “ Board ”) of Aclarion, Inc., a Delaware corporation (the “ Company ”), adopted a stockholder rights agreement and declared (i) a dividend of one right (a “ Right ”) for each outstanding share of Company common stock”
BSTT Blackstone Real Estate Income Trust, Inc.

Blackstone Real Estate Income Trust, Inc. issued 1,009,093 of common stock to a feeder vehicle primarily created to hold the Company's Class I common stock and Class C common stock for $16,619,859.

“On February 12, 2026 and March 13, 2026, Blackstone Real Estate Income Trust, Inc., a Maryland corporation (the “Company”), sold unregistered shares (the “Shares”) of the Company’s Class C common stock to a feeder vehicle primarily created to hold the Company's Class I common stock and Class C common stock, which in turn offers interests in itself to certain non-U.S. persons. The offer and sale of the Shares was exempt from the registration provisions of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2) and Regulation S thereunder. The following table details the Shares sold to such feeder vehicle: Date of Unregistered Sale Number of Class C Common Shares Issued to Feeder Vehicle Consideration February 12, 2026 231,365 $3,788,510 March 13, 2026 1,009,093 $16,619,859”
BSTT Blackstone Real Estate Income Trust, Inc.

Blackstone Real Estate Income Trust, Inc. issued 231,365 of common stock to a feeder vehicle primarily created to hold the Company's Class I common stock and Class C common stock for $3,788,510.

“On February 12, 2026 and March 13, 2026, Blackstone Real Estate Income Trust, Inc., a Maryland corporation (the “Company”), sold unregistered shares (the “Shares”) of the Company’s Class C common stock to a feeder vehicle primarily created to hold the Company's Class I common stock and Class C common stock, which in turn offers interests in itself to certain non-U.S. persons. The offer and sale of the Shares was exempt from the registration provisions of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2) and Regulation S thereunder. The following table details the Shares sold to such feeder vehicle: Date of Unregistered Sale Number of Class C Common Shares Issued to Feeder Vehicle Consideration February 12, 2026 231,365 $3,788,510 March 13, 2026 1,009,093 $16,619,859”
REVB REVELATION BIOSCIENCES, INC.

REVELATION BIOSCIENCES, INC. issued warrant to Class J Common Stock warrant holders.

“Pursuant to the terms of the Class J Common Stock Warrants, the expiration date of such warrants is five years from the date of stockholder approval; accordingly, following stockholder approval on March 18, 2026, the expiration date of the warrants is March 18, 2031.”
RIVN Rivian Automotive, Inc. / DE

Rivian Automotive, Inc. / DE issued warrant to SMB Holding Corporation.

“The Pre-Funded Warrants will have an exercise price of $0.001 per Warrant Share, subject to customary adjustments, and will be exercisable at any time after original issuance and will not expire until exercised in full.”
RIVN Rivian Automotive, Inc. / DE

Rivian Automotive, Inc. / DE issued common stock to SMB Holding Corporation for $300 million.

“the Company will issue a number of shares of Common Stock to SMB equal to $300 million divided by the price per share of Common Stock”
Signing Day Sports, Inc.

Signing Day Sports, Inc. issued 3,172,704 shares of common stock to Boustead Securities, LLC.

“On March 13, 2026, the Company issued 3,172,704 shares (the “Additional Termination Shares”) of common stock, par value $0.0001 per share, of the Company (the “Signing Day Sports common stock”), to Boustead Securities, LLC (“Boustead”), pursuant to the Termination Agreement”
AB Private Lending Fund

AB Private Lending Fund issued 56,332 of common stock to feeder vehicles primarily created to hold the Fund's Class I shares for $1,408,296.50.

“sold unregistered Class I common shares of beneficial interest (with the final number of shares being determined on March 19, 2026) to feeder vehicles primarily created to hold the Fund’s Class I shares. The offer and sale of these Class I shares was exempt from the registration provisions of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) and/or Regulation S thereunder (the “ Private Offering ”). The following table details the shares sold: Date of Unregistered Sale Amount of Class I shares Consideration As of March 2, 2026 (number of shares finalized on March 19, 2026) 56,332 $ 1,408,296.50”
WOLF WOLFSPEED, INC.

WOLFSPEED, INC. issued $379,000,000 aggregate principal amount of convertible note to the investor parties thereto.

“The Notes Subscription Agreements provide for the sale and issuance by the Company of $379,000,000 aggregate principal amount of the Company’s 3.5% Convertible 1.5 Lien Senior Secured Notes due 2031 (the “Notes” and, together with the Equity Securities, the “Securities”) in a private placement (the “Notes Placement” and, together with the Equity Securities Placement, the “Private Placements”) to such investors.”
WOLF WOLFSPEED, INC.

WOLFSPEED, INC. issued up to an aggregate of 2,000,000 shares of Common Stock of warrant to certain investors (the "Equity Securities Investors") for $18.448 per Pre-Funded Warrant.

“The Purchase Agreement provides for the sale and issuance by the Company of an aggregate of: (i) 3,250,030 shares (the “Shares”) of the Company’s common stock, par value $0.00125 per share (the “Common Stock”) and (ii) pre-funded warrants (the “Pre-Funded Warrants,” and, together with the Shares, the “Equity Securities”) to purchase up to an aggregate of 2,000,000 shares of Common Stock in a private placement (the “Equity Securities Placement”). The price per Share is $18.458, and the price per Pre-Funded Warrant is $18.448.”
WOLF WOLFSPEED, INC.

WOLFSPEED, INC. issued 3,250,030 shares of common stock to certain investors (the "Equity Securities Investors") for $18.458 per share.

“The Purchase Agreement provides for the sale and issuance by the Company of an aggregate of: (i) 3,250,030 shares (the “Shares”) of the Company’s common stock, par value $0.00125 per share (the “Common Stock”) and (ii) pre-funded warrants (the “Pre-Funded Warrants,” and, together with the Shares, the “Equity Securities”) to purchase up to an aggregate of 2,000,000 shares of Common Stock in a private placement (the “Equity Securities Placement”). The price per Share is $18.458, and the price per Pre-Funded Warrant is $18.448.”
SRXH SRx Health Solutions, Inc.

SRx Health Solutions, Inc. issued 22,237,666 Warrants to purchase shares of Common Stock of warrant to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.

“On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.”
SRXH SRx Health Solutions, Inc.

SRx Health Solutions, Inc. issued 5,660 shares of the Series B Preferred Stock of preferred stock to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.

“On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.”
ARTL ARTELO BIOSCIENCES, INC.

ARTELO BIOSCIENCES, INC. issued convertible note to Boot Capital LLC for aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00.

“limited liability company (“Boot” and together with Vanquish , the “Buyers”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00 (the “Boot Note” and together with the Vanquish Note, the “Notes”). The”
ARTL ARTELO BIOSCIENCES, INC.

ARTELO BIOSCIENCES, INC. issued convertible note to Vanquish Funding Group Inc. for aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00.

“Agreement”), with Vanquish Funding Group Inc., a Virginia corporation (“Vanquish”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00 (the “Vanquish Note”). Additionally, on March 12, 2026, the Company”
OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc. issued 10,701,710 pre-funded warrants of warrant to the Investors for purchase price of $2.009 per Pre-Funded Warrant.

“On March 17, 2026, Ovid Therapeutics Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Investors”), pursuant to which the Company agreed to issue and sell an aggregate of 19,154,321 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), at a purchase price of $2.01 per share and, in lieu of Common Stock, pre-funded warrants to purchase up to 10,701,710 shares of Common Stock (the “Pre-Funded Warrants” and, together with the Shares, the “Securities”) at a purchase price of $2.009 per Pre-Funded Warrant, to the Investors in a private placement (the “PIPE financing”).”
OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc. issued 19,154,321 shares of common stock of common stock to the Investors for purchase price of $2.01 per share.

“On March 17, 2026, Ovid Therapeutics Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Investors”), pursuant to which the Company agreed to issue and sell an aggregate of 19,154,321 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), at a purchase price of $2.01 per share and, in lieu of Common Stock, pre-funded warrants to purchase up to 10,701,710 shares of Common Stock (the “Pre-Funded Warrants” and, together with the Shares, the “Securities”) at a purchase price of $2.009 per Pre-Funded Warrant, to the Investors in a private placement (the “PIPE financing”).”
SEGG Sports Entertainment Gaming Global Corp

Sports Entertainment Gaming Global Corp issued The Notes are convertible into shares of Common Stock of convertible note to certain institutional investors for initial principal amount of $3,529,411.76 with 15% OID.

“of Regulation D promulgated thereunder. The Notes will be issued in multiple tranches as follows: (i) an initial tranche (the “ Initial Tranche ”) in an aggregate face amount of $3,529,411.76, to be funded upon execution of the transaction documents; (ii) a second tranche in an aggregate face amount of $588,235.29, to be funded upon filing of the Registration”
ExchangeRight Income Fund

ExchangeRight Income Fund issued 30,771 shares of common stock for $898,000.

“506(c) of Regulation D promulgated thereunder. The following table details the shares sold: Number of Gross Share Class Shares Sold Proceeds Class ER-A Common Shares 30,771 $ 898,000 * * Includes selling commissions described above Forward-Looking Statements Certain statements contained in this Current Report on Form 8-K other than historical facts may be”
APHP American Picture House Corp

American Picture House Corp issued 200,000 shares of common stock to Labrys Fund II, LP.

“the Company agreed to issue 200,000 shares of its common stock to Labrys as commitment shares.”
APHP American Picture House Corp

American Picture House Corp issued common stock to Bannor Michael MacGregor and The Noah Morgan Private Family Trust.

“As described in Item 1.01 above, on March 12, 2026, in connection with the Board’s approval of the Multi-Film Agreement, the Company became obligated, subject to the terms of such agreement and applicable approvals, to issue equity consideration consisting of $350,000 in value of shares of the Company’s common stock to Bannor Michael MacGregor and The Noah Morgan Private Family Trust, to be split equally.”
LASE Laser Photonics Corp

Laser Photonics Corp issued up to 96,154 shares of warrant to Wainwright or its designees.

“a placement agent warrant to Wainwright or its designees to purchase up to 96,154 shares of the Company’s common stock”
LASE Laser Photonics Corp

Laser Photonics Corp issued up to an aggregate of 1,373,630 shares of warrant to holders of existing Series A and Series B warrants.

“Series A-3 warrants to purchase up to an aggregate of 1,373,630 shares of the Company’s common stock”
EDBL Edible Garden AG Inc

Edible Garden AG Inc issued 50,840 shares of the Company's common stock of common stock to Streeterville Capital, LLC for exchange of 121 shares of Series B Preferred Stock with aggregate stated value of $121,000.

“On March 12, 2026, Edible Garden AG Incorporated (the "Company") entered into exchange agreements (the "Exchange Agreements") with Streeterville Capital, LLC, a Utah limited liability company ("Streeterville") pursuant to which the Company agreed to exchange 121 shares, of the Company’s Series B Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), for a total of 50,840 shares of the Company’s common stock, par value $0.0001 per share ("Exchange Shares").”
HYPR Hyperfine, Inc.

Hyperfine, Inc. issued 520,835 shares of warrant to Horizon Technology Finance Corporation for $1.20 per share.

“the Company issued to the Lender (i) warrants to purchase up to an aggregate of 562,500 shares (the “Initial Warrants”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and (ii) warrants to purchase up to an aggregate of 520,835 shares (the “Additional Warrants”) of Common Stock, in each case at an exercise price of $1.20 per share (collectively, the “Warrants”).”
HYPR Hyperfine, Inc.

Hyperfine, Inc. issued 562,500 shares of warrant to Horizon Technology Finance Corporation for $1.20 per share.

“the Company issued to the Lender (i) warrants to purchase up to an aggregate of 562,500 shares (the “Initial Warrants”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and (ii) warrants to purchase up to an aggregate of 520,835 shares (the “Additional Warrants”) of Common Stock, in each case at an exercise price of $1.20 per share (collectively, the “Warrants”).”
ECD Automotive Design, Inc.

ECD Automotive Design, Inc. issued convertible note to an institutional investor (the "Holder") for original principal amount of $2,663,770 for a purchase price of $2,424,667.

“the Holder exercised its right to purchase additional Notes in the original principal amount of $2,663,770 for a purchase price of $2,424,667”
NWTG Newton Golf Company, Inc.

Newton Golf Company, Inc. issued Warrant to purchase 50,000 Shares of Common Stock of warrant to entities affiliated with and controlled by Brett Hoge, one of the Company’s directors for purchased as part of the First Closing; cash proceeds referenced for the overall Securities.

“The first closing occurred on March 16, 2026 (the “First Closing”) at which the Company issued, and the purchasers purchased, a Convertible Note with a principal amount of $500,000 and a Warrant to purchase 50,000 Shares of Common Stock (the “Warrant Shares”).”
NWTG Newton Golf Company, Inc.

Newton Golf Company, Inc. issued $500,000 principal amount Convertible Note of convertible note to entities affiliated with and controlled by Brett Hoge, one of the Company’s directors for cash proceeds of $500,000.

“The first closing occurred on March 16, 2026 (the “First Closing”) at which the Company issued, and the purchasers purchased, a Convertible Note with a principal amount of $500,000 and a Warrant to purchase 50,000 Shares of Common Stock (the “Warrant Shares”). Such purchasers of the Securities are entities affiliated with, and controlled by Brett Hoge, one”
CETI Cyber Enviro-Tech, Inc.

Cyber Enviro-Tech, Inc. issued one (1) share of preferred stock to Kim D. Southworth for No cash consideration.

“On March 11, 2026, Cyber Enviro-Tech, Inc. (the “Company”) issued one (1) share of its Special 2025 Series A Preferred Stock (the “Preferred Stock”) to Kim D. Southworth, the Company’s Chief Executive Officer.”
Blue Owl Real Estate Net Lease Trust

Blue Owl Real Estate Net Lease Trust issued 2,156,113 shares of common stock to feeder vehicles primarily created to hold the Company's Class I common shares for gross proceeds of approximately $22.9 million.

“As of March 2, 2026, Blue Owl Real Estate Net Lease Trust (the “ Company ”, “ we ”, or “ us ”) sold 2,156,113 shares of its Class I common shares (with the final number of shares being determined on March 16, 2026) to feeder vehicles primarily created to hold the Company’s Class I common shares for gross proceeds of approximately $22.9 million, based on net asset value (“ NAV ”) per share as of February 28, 2026.”
26North BDC, Inc.

26North BDC, Inc. issued approximately 2,527,641 shares of common stock to accredited investors and non-U.S. persons for gross proceeds of approximately $63.4 million.

“On March 12, 2026, 26North BDC, Inc. (the "Company") issued and sold approximately 2,527,641 shares of the Company’s common stock, par value $0.001 per share (the "Common Stock"), resulting in gross proceeds of approximately $63.4 million.”
Blue Owl Digital Infrastructure Trust

Blue Owl Digital Infrastructure Trust issued an aggregate of 5,321,372 of its common shares of common stock to various investors for gross proceeds of approximately $54.1 million.

“Item 3.02. Unregistered Sale of Equity Securities. On March 2, 2026, Blue Owl Digital Infrastructure Trust (the “Company”) sold an aggregate of 5,321,372 of its common shares (with the final number of shares being determined on March 16, 2026) for gross proceeds of approximately $54.1 million, based on net asset value (“NAV”) per share as of February 28, 2026.”
CMCT Creative Media & Community Trust Corp

Creative Media & Community Trust Corp issued 51,027,328 shares of Common Stock in respect of redemptions of Series A Preferred Stock, 206,166,177 shares of Common Stock in respect of redemptions of Series of common stock to holders of Preferred Stock for redemption of 1,869,573 shares of Series A Preferred Stock, 7,539,638 shares of Series A1 Preferred Stock and 21,760 shares of Series D Preferred Stock.

“On March 16, 2026, the Company arranged for the issuance of 51,027,328 shares of Common Stock in respect of redemptions of Series A Preferred Stock, 206,166,177 shares of Common Stock in respect of redemptions of Series A1 Preferred Stock and 594,090 shares of Common Stock in respect of redemptions of Series D Preferred Stock, in each case, based on the VWAP of the Common Stock for the 20 Trading Days immediately preceding March 16, 2026.”
CMCT Creative Media & Community Trust Corp

Creative Media & Community Trust Corp issued 1,106,594 shares of Common Stock in respect of redemptions of Series A Preferred Stock and 2,322,421 shares of Common Stock in respect of redemptions of Series of common stock to holders of Preferred Stock for redemption of 88,250 shares of Series A Preferred Stock and 194,492 shares of Series A1 Preferred Stock.

“On March 12, 2026, the Company arranged for the issuance of 1,106,594 shares of Common Stock in respect of redemptions of Series A Preferred Stock and 2,322,421 shares of Common Stock in respect of redemptions of Series A1 Preferred Stock, in each case, based on the VWAP of the Common Stock for the 20 Trading Days immediately preceding March 12, 2026.”
HNOI HNO International, Inc.

HNO International, Inc. issued convertible note to CFI Capital LLC for aggregate principal amount of $150,000, with a $12,000 original issue discount, resulting in a purchase price of $138,000.

“CFI Capital LLC (the " Buyer "), pursuant to which the Company issued to the Buyer a Convertible Redeemable Promissory Note (the " Note ") in the aggregate principal amount of $150,000, with a $12,000 original issue discount, resulting in a purchase price of $138,000. The Buyer may deduct $5,000 for legal fees from the proceeds at funding, resulting in net”
DARE Dare Bioscience, Inc.

Dare Bioscience, Inc. issued 43,050 Investor Units consisting of 43,050 shares of Series A Preferred Stock and Investor Warrants to purchase up to 86,100 shares of our common stock of unit for $5.00.

“On March 16, 2026, Daré Bioscience, Inc. (“Daré” “we,” “us,” or “our”) completed a closing of our previously announced Regulation A offering of up to 4,854,000 units (each, an “Investor Unit” and collectively the “Investor Units”), each consisting of one share of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) and two warrants, each to purchase one share of our common stock (“Investor Warrants”), with each Investor Unit being offered at an offering price of $5.00 (the “Offering”). In connection therewith, we issued an aggregate of 43,050 Investor Units consisting of 43,050 shares of Series A Preferred Stock and Investor Warrants to purchase up to 86,100 shares of our common stock.”
AKTX Akari Therapeutics Plc

Akari Therapeutics Plc issued common stock.

“On March 17, 2026, Akari Therapeutics, Plc (the “Company”) announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) evidencing ordinary shares, par value 0.000000005 per share (“Ordinary Shares”), from one (1) ADS representing two thousand (2,000) Ordinary Share to one (1) ADS representing eighty thousand (80,000) Ordinary Shares (the “Ratio Change”).”
TNON Tenon Medical, Inc.

Tenon Medical, Inc. issued convertible note to certain accredited investors for aggregate gross proceeds of approximately $4.3 million.

“the Company agreed to issue and sell in a private placement an aggregate principal amount of $4.3 million 20% Original Issue Discount Senior Convertible Promissory Notes (the “Notes”) for aggregate gross proceeds of approximately $4.3 million”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.